STOCK TITAN

ALR Technologies (ALRTF) details Canada GluCurve Pet CGM launch in Form 6-K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

ALR Technologies SG Ltd. filed a Form 6-K as a foreign private issuer, mainly to furnish a press release as an exhibit. The press release, dated May 19, 2026, announces the launch of the company’s GluCurve Pet CGM in Canada, signaling a new product introduction in that market.

Positive

  • None.

Negative

  • None.
Commission File Number 000-56491 Form 6-K registration reference
Form type Form 6-K Report of foreign private issuer
Press release exhibit Exhibit 99.1 Press release announcing GluCurve Pet CGM launch in Canada
Press release date May 19, 2026 Dated press release furnished as Exhibit 99.1
Form 6-K signature date May 20, 2026 Date the report was signed by the CEO
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Securities Exchange Act of 1934 regulatory
"PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934"
Exhibit 99.1 regulatory
"Exhibit 99.1 | Press Release dated May 19, 2026"
Exhibit 99.1 is a label used in regulatory filings to identify a specific attached document, most often a company press release or investor presentation filed with securities regulators. For investors it matters because it marks an official, contemporaneous source of information directly tied to a filing—like the original news article pinned to a legal record—so traders and analysts treat it as an authoritative statement that can move a stock or clarify a company’s situation.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2026

 

____________________       

 

Commission File Number: 000-56491

 

ALR Technologies SG Ltd.

(Translation of registrant’s name into English)

 

 

9 Raffles Place

#26-01 Republic Plaza

Singapore

Singapore 048619

(Address of principal executive office)

____________________

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

 

 

CONTENTS

 

On May 19, 2026, ALR Technologies SG Ltd. issued a press release, a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K and incorporated by reference herein.

 

Exhibit Number Description of Exhibit
99.1 Press Release dated May 19, 2026, Announcing the Launch of GluCurve Pet CGM in Canada

 

 

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undesigned, thereunto duly authorized.

 

Date: May 20, 2026

 

 

ALR Technologies SG Ltd.

 

By: s/ Sidney Chan

Name: Sidney Chan

Title: CEO

 

 

 

 

Exhibit 99.1

 

 

 

 

 

 

FAQ

What did ALR Technologies (ALRTF) report in its May 2026 Form 6-K?

ALR Technologies SG Ltd. filed a Form 6-K to furnish a press release as Exhibit 99.1. The release, dated May 19, 2026, announces the launch of its GluCurve Pet CGM product in Canada, highlighting a product introduction in that market.

What is the main announcement in ALRTF’s attached press release?

The attached press release announces the launch of GluCurve Pet CGM in Canada. It is dated May 19, 2026 and is furnished as Exhibit 99.1, forming the primary content of ALR Technologies SG Ltd.’s May 2026 Form 6-K filing.

Which exhibit is included with ALR Technologies SG Ltd.’s May 2026 Form 6-K?

The Form 6-K includes Exhibit 99.1, described as a press release dated May 19, 2026. That press release announces the launch of GluCurve Pet CGM in Canada and is incorporated by reference into the Form 6-K report.

When was ALR Technologies’ GluCurve Pet CGM launch in Canada announced?

The launch of GluCurve Pet CGM in Canada was announced in a press release dated May 19, 2026. This press release is furnished as Exhibit 99.1 and incorporated by reference in ALR Technologies SG Ltd.’s May 2026 Form 6-K filing.

Where is ALR Technologies SG Ltd.’s principal executive office located?

ALR Technologies SG Ltd.’s principal executive office is located at 9 Raffles Place #26-01, Republic Plaza, Singapore 048619. This Singapore address is listed in the Form 6-K as the company’s main executive office location.

Who signed ALR Technologies SG Ltd.’s May 2026 Form 6-K filing?

The Form 6-K was signed on behalf of ALR Technologies SG Ltd. by Sidney Chan. The signature block identifies Sidney Chan as the company’s CEO, executing the report pursuant to the Securities Exchange Act of 1934.

Filing Exhibits & Attachments

3 documents